A 28-year-old woman undergoes routine cervical screening and is found to have ASC-US (Atypical Squamous Cells of Undetermined Significance) on Pap smear. Which is the most appropriate next investigation according to current guidelines?

Explanation

## Triage of ASC-US: HPV Reflex Testing ### Current Management Algorithm for ASC-US **Key Point:** HPV reflex testing is the recommended triage strategy for ASC-US cytology. HPV-positive ASC-US patients proceed to colposcopy; HPV-negative patients are reassured and returned to routine screening. ### Why HPV Reflex Testing? 1. **Risk Stratification**: ASC-US carries ~5–10% risk of underlying CIN2+. HPV status identifies which patients truly need further investigation. 2. **Cost-Effective**: Avoids unnecessary colposcopy in HPV-negative women (~60–70% of ASC-US cases). 3. **Evidence-Based**: Endorsed by ASCCP (American Society for Colposcopic Cervical Pathologists), ACOG, and WHO guidelines. 4. **High Sensitivity**: HPV testing detects ~95% of CIN2+ lesions; HPV-negative ASC-US has <1% risk of CIN2+. ### Management Pathway for ASC-US ```mermaid flowchart TD A[ASC-US on Pap Smear]:::outcome --> B[HPV Reflex Testing]:::action B --> C{HPV Result?}:::decision C -->|HPV Positive| D[Colposcopy]:::action C -->|HPV Negative| E[Return to Routine Screening]:::outcome D --> F{Colposcopy Findings?}:::decision F -->|CIN2+| G[Excisional Procedure]:::action F -->|CIN1 or Normal| H[HPV Testing in 12 months]:::action ``` ### HPV Testing Methods | Method | Sensitivity | Specificity | Use | |---|---|---|---| | **Hybrid Capture 2 (HC2)** | 95–97% | 94–96% | Gold standard for reflex testing | | **PCR-based HPV DNA** | 95–98% | 92–95% | More sensitive, genotype-specific | | **Liquid-based Cytology HPV** | 90–95% | 90–94% | Convenient (same specimen as Pap) | ### Clinical Pearl **High-Yield:** Remember the **"HPV-positive ASC-US = colposcopy; HPV-negative ASC-US = routine screening"** rule. This single triage step prevents overtreatment while ensuring no CIN2+ is missed. **Warning:** Do NOT perform immediate colposcopy on all ASC-US patients — this leads to unnecessary procedures and anxiety. Do NOT repeat Pap smear alone — it delays diagnosis and increases risk. ### What NOT to Do - ~~Repeat Pap smear in 12 months~~ → Delays diagnosis; low sensitivity for CIN2+. - ~~Immediate colposcopy~~ → Overtreatment; 60–70% of ASC-US are HPV-negative and do not need colposcopy. - ~~Cervical biopsy~~ → Premature; colposcopy must precede biopsy to identify lesion location. [cite:Park 26e Ch 21]